A B S T R A C T Kidney transplant recipients were previously found to have antibodies that reacted with cells isolated from the endothelium of umbilical cord veins and which were not cytotoxic for lymphocytes from the same donors. Results of the present experiments indicate that endothelial (E) antigens are different from previously known HLA antigens and also from Ia-like antigens of bone marrow-derived (B) lymphocytes. Attempts to absorb E antibodies with lymphocytes from E-positive donors failed in most cases. Antigen redistribution experiments shoved that E antigens were located in separate molecules from the products of HLA-A, B, and C. Thus, E cells treated with E antibody became resistant to lysis by the antibody used, but remained susceptible to the effects of typing sera for alleles of HLA-A, B, and C. Antibodies to E cells were also cytotoxic for blood monocytes. Moreover, monocytes were able to absorb E-antibody reactions, indicating that similar antigens were expressed in both cells. E antibodies did not react with B lymphocytes isolated from peripheral blood. In that regard E antibodies were different from antibodies to human Ialike antigens which reacted with E cells, monocytes, and isolated B lymphocytes. Thus it appears that E antigens constitute a system of human alloantigens which has not been previously identified. The possibility that these antigens play a role in kidney allograft rejection should now be investigated since matching can be performed using monocytes isolated from the blood of recipients and donors.
INTRODUCTION
The HLA region of the sixth human chromosome (1) contains, in addition to the main histocompatibility Dr. Moraes is the recipient of fellowships from the Pan American Health Organization and Ministerio da Educacao e Cultura (CAPES), Brazil.
Received for publication 19 October 1976 and in revised form 18 April 1977. loci HLA-A, HLA-B, and HLA-C, the more recently defined HLA-D locus which controls strong stimulation in mixed lymphocyte cultures (2) and others such as loci for Ia-like antigens expressed preferentially in bone marrow-derived (B) lymphocytes (3) (4) (5) and for complement components (6) (7) (8) produced by macrophages (9) . By analogy with homologous chromosomal regions in other species, the HLA region probably also controls cellular interactions and participates in the regulation of the immune response (10) (11) (12) . The success of kidney allografts from HLA-matched siblings, in immunosuppressed hosts, is evidence that the HLA region is the main barrier to human kidney transplantation. Compared to chromosome matching as performed when donors are sought in families, HLAantigen matching with lymphocytes as commonly performed for cadaveric kidney transplantation, has been less effective in predicting the outcome of unrelated allografts (13) . Since matching either by serologic methods or by mixed lymphocyte cultures has usually been performed with lymphocytes, and since the products of some HLA loci are not expressed equally in all cells, it is appropriate to ask whether the kidney might express antigens important for transplantation which are not detected in lymphocytes of peripheral blood (14) . It is known that some transplant recipients do not develop lymphocytotoxic antibodies even after allograft rejection (15) , and administration of lymphocytes, in the form of random blood transfusions before transplantation, appears to have no adverse effect on survival of subsequent kidney allografts (16) .
Vascular endothelium is rich in alloantigens which can be detected serologically (17) and in mixed lymphocyte cultures (18) . It constitutes a large surface of contact over which host blood flows into the grafted organ and is likely to be a source of antigenic stimulation. Vascular lesions are known to play a predominant role in kidney allograft failure (19) .
In a previous report, sera from transplant recipients were found to contain antibodies against endothelial (20) . The veins were cannulated at each end and washed with PBS to remove retained blood (Fig. 1) to each reaction mixture. The complement used was known from preliminary tests not to be toxic for E cells. Incubation with complement was allowed to continue for 60 min at room temperature. The trays were then refrigerated and read as soon as possible. Readings were performed using a Leitz fluorescence microscope equipped with a dry darkfield condenser and a 10 x objective (E. Leitz, Rockleigh, N. J.). Live cells in control preparations showed bright green fluorescence. A decrease of 50% was required for a positive score. If more than 80% of the cells were killed, a reaction was scored strong positive. Cytotoxicity tests with monocytes were performed similarly. Tests with B lymphocytes were incubated with complement for 2 h and readings were made using eosin staining instead of fluorochromasia.
HLA-typing. Antisera used to identify the antigens of HLA-A, B, and C were derived from the local pregnancy serum screening program, or obtained from the National Institutes of Health serum bank and from other investigators. With these reagents it was possible to identify all the World Health Organization and the International Union of Immunological Societies' established alleles (1), however, certain sera which were in short supply, particularly those for HLA-CW1 through CW5, were not used in the typing of all the donors. In the antigen redistribution experiments, sera of the 6th International Histocompatibility Workshop were used. The typing procedure employed in these tests was the same cytotoxicity method described above. Antigen redistribution tests by the resistance-induction method. The procedure to test for the molecular independence of antigens on the surface of E cells was based on development of specific resistance to antibody-mediated lysis as described by Bemoco and co-workers (27) and more recently by Hauptfeld and co-workers (28 Antigen redistribution experiments were performed by the resistance-induction method (27, 28) to investigate whether E antigens are separate from the products of the HLA-A, B, and C loci. In these experiments, resistance to lysis developed after treatment with specific anti-E antibodies, but the treated E cells remained susceptible to the cytotoxic effects of anti-HLA-A, B, and C reagents. The concordant reactions of several typing sera of high quality is strong evidence that the HLA-A, B, and C antigens were not affected by the "stripping" procedure. Although it is not known whetfier resistance to cytolysis in such experiments is actually due to removal (stripping) of the molecules as in antigen redistribution observed by immunofluorescence, it is well established that the method has a high degree ofspecificity (27, 28) . Thus, E antigens appear to be distinct and most likely located in separate molecules on the surface of E cells.
Because of the possibility that E antigens might be expressed in a subpopulation of cells from peripheral blood, mononuclear cells were separated into adherent and nonadherent cells by incubation in Petri dishes. The results of cytotoxicity tests showed that E antibodies did not react with lymphocytes but that cytotoxicity for monocytes and E cells was concordant in most cases. Moreover blood monocytes were able to absorb the E antibody reactions. These absorptions were possible only with reactive monocytes, indicating that the effect of the monocytes was antigen specific. Thus, it appears that E antigens are expressed in blood monocytes in addition to endothelium.
It is now well known that products of the HLA-D region responsible for strong stimulation in mixed lymphocyte cultures and the Ia-like molecules that are targets for cytotoxic antibodies are expressed preferentially in B lymphocytes and monocytes, and are not detectable by cytotoxicity or immunofluorescence in T lymphocytes from human blood (3) (4) (5) . Since E cells (18) and macrophages (29) stimulate allogeneic lymphocytes in cultures it seems likely that these cells also express HLA-D-region products. Thus, one could have assumed that the E antigens here described, were the same as the Ia-like determinants. The reactions observed with sera known to contain antibodies against Ia-like antigens of human B lymphocytes were in agreement with the possibility that Ia-like antigens exist in B lymphocytes, monocytes, and E cells. In contrast, sera selected because they were known to contain anti-E antibodies reacted with E cells and monocytes, but B lymphocytes were negative. Since anti-Ia sera killed from 50 to 90% of the cells in B lymphocyte preparations, absence of reaction of anti-E sera was likely to be significant and suggested that E antigens and Ia-like alloantigens were not the same. In other experiments,2 it has been observed that anti-E antibodies were not absorbed by incubation with normal B-lymphocyte preparations or cultured Bcell lines. It is therefore unlikely that absence of reaction with B lymphocytes could be due to cytotoxicitynegative, absorption-positive reactions. Furthermore, in preliminary experiments,2 using the lysostrip technique, E cells that developed resistance to E-antibodies remained susceptible to lysis by anti-Ia sera. It must be concluded, therefore, that E antigens are separate and distinct from the Ia-like antigens.
Using methods traditional in HLA serology, it has been possible to identify eight allelic E specificities (30) . There was one triplet in a panel of 30 cells, suggesting that the specificities were controlled by a single genetic locus. If these antigens do play a role in kidney transplantation, matching of donors and recipients for E antigens and cross matching recipient serum with donor monocytes would certainly be a possibility.
